|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.12 EUR | -23.13% |
|
-19.22% | -50.66% |
| 2023 | Biosynex: merger with Theradiag completed | CF |
| 2023 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Biosynex announced earnings results for the full year of 2013. For the year, the company reported net loss expand to EUR 1.36 million (USD 1.9 million) in 2013 from EUR 710,000 in 2012. Operating loss widened to EUR 1.49 million from EUR 740,000.
Revenues remained stable at EUR 5.57 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -50.66% | 61.64M | |
| -1.09% | 12.72B | |
| -12.53% | 7.5B | |
| +0.45% | 5.48B | |
| -1.37% | 4.61B | |
| +5.16% | 4.47B | |
| -51.93% | 3.28B | |
| +11.34% | 2.71B | |
| -19.05% | 2.02B | |
| -11.07% | 1.74B |
BIOSYNEX 
